Skip to main content
OpenTrials

Clinical trial condition

Solid Tumor

Explore clinical trials studying Solid Tumor. Study availability and eligibility vary by location and protocol.

717 public trials 251 recruiting studies
Refine in advanced search Browse all conditions

Solid Tumor trial results

Completed

JAB-BX102 Monotherapy and Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors

NCT05174585

Conditions
Solid Tumor
Locations
  • The First Affiliated Hospital of Bengbu Medical College Bengbu, Anhui, China
  • Cancer Hospital Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China
View Trial Details
Completed

A Study of RC108-ADC in Subjects With Advanced Malignant Solid Tumors

NCT04617314

Conditions
Solid Tumor
Locations
  • National Cancer Center/Cancer Hospital, Chinese Academy of Medical Science and Peking Union Medical College Beijing, Beijing Municipality, China
  • Hunan Cancer Hospital Changsha, Hunan, China
  • The First Hospital of Jilin University Changchun, Jilin, China
  • Zhejiang Cancer Hospital Hangzhou, Zhejiang, China
View Trial Details
Completed

Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor in Patients With Advanced Solid Tumor

NCT04648254

Conditions
Advanced Cancer, Metastatic Cancer, Neoplasm Metastasis, +5 more
Locations
  • University of Southern California Los Angeles, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Northwestern University Chicago, Illinois, United States
  • Atlantic Health System Hospital Morristown, New Jersey, United States
View Trial Details
Completed

A Study of LP-118 in Patients With Advanced Tumors

NCT05025358

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Guangdong Provincial People's Hospital Guangzhou, Guangdong, China
  • The First Affiliated Hospital of Jinan University Guangzhou, Guangdong, China
  • Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology Wuhan, Hubei, China
  • First Affiliated Hospital of Zhejiang University School of Medicine Hangzhou, Zhejiang, China
View Trial Details
Completed

Study of Niraparib, TSR-022, Bevacizumab, and Platinum-Based Doublet Chemotherapy in Combination With TSR-042

NCT03307785

Conditions
Advanced Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +17 more
Locations
  • GSK Investigational Site Scottsdale, Arizona, United States
  • GSK Investigational Site Encinitas, California, United States
  • GSK Investigational Site San Marcos, California, United States
  • GSK Investigational Site Sarasota, Florida, United States
View Trial Details
Completed

Afuresertib +Sintilimab+Chemotherapy in Patients With Selected Solid Tumors That Resistance to Prior Anti-PD-1/PD-L1

NCT05383482

Conditions
Cervical Cancer, Digestive System Diseases, Digestive System Neoplasms, +24 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Chongqing Cancer Hospital Chongqing, Chengdu, China
  • Jilin Cancer Hospital Changchun, Jilin, China
  • Zhongshan Hospital, Fudan University Shanghai, Shanghai Municipality, China
View Trial Details
Completed

Study of Boserolimab (MK-5890) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Adults With Advanced Solid Tumors (MK-5890-001)

NCT03396445

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +15 more
Locations
  • University of South Alabama, Mitchell Cancer Institute ( Site 0020) Mobile, Alabama, United States
  • Florida Cancer Specialists ( Site 0002) Sarasota, Florida, United States
  • The West Clinic, P.C. ( Site 0021) Germantown, Tennessee, United States
  • FALP-UIDO ( Site 0502) Santiago, Region M. de Santiago, Chile
View all 18 locations
View Trial Details

Related conditions